Hyperliquid Strategies Inc (PURR:NASDAQ) closed at $8.78 on October 23, 2026, up 1.15% on the day. The stock trades 40.5% below its 52-week high of $14.76 and 191.7% above its 52-week low of $3.01. Over the past year, it gained 125.1%. Hyperliquid Strategies Inc is part of the Health Care sector.
In 223 trading sessions since December 4, 2025, PURR closed higher on 106 days (48%). Its best day was August 19, 2026 (+30.42%) and its worst was February 23, 2026 (-11.89%). The stock moved 10% or more in a single session 21 times. It opened at least 5% above the previous day's high 8 times.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
Find more stocks like PURR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.